Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Ovarian Neoplasms × niraparib × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 52 Observational 6 Expanded_access 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1

Interventions

ulixertinib 1 pegilodecakin 1 olaparib 1 niraparib 1 balstilimab 1 Proton Pump Inhibitors 1 Hydrocortisone 1 FANG vaccine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025867 2017-04-17

Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

Tesaro, Inc.

Approved for marketing

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡